Tandem Therapeutic Plasma Exchange Reduces Continuous Renal Replacement Therapy Downtime

被引:1
作者
Foglia, Matthew J. [1 ]
Pelletier, Jonathan H. [2 ]
Bayir, Hulya [1 ,2 ,3 ,4 ]
Fleck, Annette [2 ,3 ]
Konyk, Leslie [2 ,3 ]
McSteen, Coleen [2 ,3 ]
Fisher, Dawn [2 ,3 ]
Fuhrman, Dana Y. [1 ,2 ,3 ]
机构
[1] UPMC Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA
[2] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Sch Med, Div Pediat Crit Care,Dept Crit Care Med, Pittsburgh, PA 15260 USA
[3] UPMC Childrens Hosp Pittsburgh, Pediatr CRRT Program, Pittsburgh, PA 15224 USA
[4] UPMC Childrens Hosp Pittsburgh, Childrens Neurosci Inst, Pittsburgh, PA 15224 USA
关键词
Renal replacement therapy; Therapeutic plasma exchange; Acute kidney injury; CRITICALLY-ILL PATIENTS; CIRCUIT LIFE-SPAN; PLASMAPHERESIS;
D O I
10.1159/000518348
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Continuous renal replacement therapy (CRRT) has become a primary treatment of severe acute kidney injury in children admitted to the intensive care unit. CRRT "downtime" (when the circuit is not active) can represent a significant portion of the prescribed treatment time and adversely affects clearance. The objective of this study was to evaluate factors associated with CRRT "downtime" and to determine whether instituting a tandem therapeutic plasma exchange (TPE) protocol could significantly and robustly decrease circuit downtime in patients receiving both therapies. Methods: This is a retrospective cohort study of 116 patients undergoing CRRT in the pediatric, neonatal, or cardiac ICU at UPMC Children's Hospital of Pittsburgh from January 2014 to July 2020. We performed multivariable logistic regression to determine factors associated with CRRT downtime. We instituted a tandem TPE protocol whereby TPE and CRRT could run in parallel without pausing CRRT in April 2018. We analyzed the effect of the protocol change by plotting downtime for patients undergoing CRRT and TPE on a run chart. The effect of initiating tandem TPE on downtime was assessed by special cause variation. Results: For 108/139 (77.7%) sessions with downtime data available, the median (IQR) percentage of downtime was 6.2% (1.7-12.7%). Multivariable logistic regression showed that TPE was significantly associated with CRRT downtime (p = 0.003), and that age, sex, race, catheter size, and anticoagulation were not. For patients undergoing TPE, the median (IQR) percentage of downtime was 14.7% (10.5-26%) and 3.4% (1.3-4.9%) before and after initiation of tandem TPE, respectively (p < 0.001). The difference in downtime percentage met criteria for special cause variation. Conclusions: Interruptions for TPE increase CRRT downtime. Tandem TPE significantly reduces CRRT downtime in patients undergoing both procedures concomitantly.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 50 条
[31]   Fluid Management on Continuous Renal Replacement Therapy [J].
Murugan, Raghavan ;
Kellum, John A. .
40 YEARS OF CONTINUOUS RENAL REPLACEMENT THERAPY, 2018, 194 :60-69
[32]   Review of Anticoagulation in Continuous Renal Replacement Therapy [J].
Roe, Neil A. ;
Wiss, Adam L. ;
Volgas, Sarah ;
Hudson, Joanna Q. .
CRITICAL CARE NURSING QUARTERLY, 2022, 45 (02) :144-155
[33]   Technical Complications of Continuous Renal Replacement Therapy [J].
Ricci, Zaccaria ;
Romagnoli, Stefano .
40 YEARS OF CONTINUOUS RENAL REPLACEMENT THERAPY, 2018, 194 :99-108
[34]   Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy [J].
Godaly, Gabriela ;
Carlsson, Ola ;
Broman, Marcus .
CLINICAL KIDNEY JOURNAL, 2016, 9 (02) :205-210
[35]   Plasma Exchange and Continuous Renal Replacement Therapy in the Treatment of Acute-on-Chronic Liver Failure Patients with Acute [J].
Ma, Zhiping ;
Zhang, Yan ;
Yao, Yunhai .
HEPATITIS MONTHLY, 2025, 25 (01)
[36]   A First Evaluation of OMNI®, A New Device for Continuous Renal Replacement Therapy [J].
Schlaepfer, Pierre ;
Durovray, Jean-Daniel ;
Plouhinec, Valery ;
Chiappa, Cristiano ;
Bellomo, Rinaldo ;
Schneider, Antoine .
BLOOD PURIFICATION, 2017, 43 (1-3) :11-17
[37]   Anticoagulation Strategies for Continuous Renal Replacement Therapy in France: A Survey of Practices [J].
Pible, Justine ;
Bidar, Frank ;
Chardon, Nicolas ;
Cerro, Valerie ;
Ichai, Carole ;
Monard, Celine ;
Schneider, Antoine ;
Joannes-Boyau, Olivier ;
Constantin, Jean-Michel ;
Rimmele, Thomas .
BLOOD PURIFICATION, 2025, 54 (01) :1-8
[38]   Current practice in continuous renal replacement therapy: An epidemiological multicenter study [J].
Tomasa Irriguible, T. M. ;
Sabater Riera, J. ;
Poch Lopez de Brinas, E. ;
Fort Ros, J. ;
Lloret Cora, M. J. ;
Roca Antonio, J. ;
Navas Perez, A. ;
Ortiz Ballujera, P. ;
Servia Goixart, L. ;
de Molina Ortiz, F. J. Gonzalez ;
Rovira Angles, C. ;
Rodriguez Lopez, M. ;
Roglan Piqueras, A. .
MEDICINA INTENSIVA, 2017, 41 (04) :216-226
[39]   The Effect of Therapeutic Hypothermia on Prognosis in Patients Receiving Continuous Renal Replacement Therapy [J].
Evren, Gultac ;
Zengin, Neslihan .
THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT, 2024, 14 (01) :52-58
[40]   Nafamostat mesilate for anticoagulation in continuous renal replacement therapy [J].
Hwang, Seun Deuk ;
Hyun, Yu Kyung ;
Moon, Sung Jin ;
Lee, Sang Choel ;
Yoon, Soo Young .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2013, 36 (03) :208-216